A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This phase II clinical trial was designed to assess the feasibility, safety, toxicity,
recurrence and survival pattern when TP or CAP chemotherapy was combined with adjuvant
radiation for patients with high-risk endometrial cancer.